Correlation of activated partial thromboplastin time versus anti-Xa levels for unfractionated heparin monitoring in postoperative pediatric liver transplant patients

被引：0
|
作者：
Brocks, Rebecca [1 ]
Lemoine, Caroline [2 ]
Brandt, Katherine [2 ]
Bhat, Rukhmi [3 ]
Superina, Riccardo [2 ]
机构：
[1] Univ Montreal, Hosp Sainte Justine, Pediat & Transplant Surg, Montreal, PQ, Canada
[2] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Div Transplant Surg, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp, Feinberg Sch Med, Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60611 USA
来源：
PEDIATRIC TRANSPLANTATION | 2022年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P6.06
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
    Vandiver, Jeremy W.
    Vondracek, Thomas G.
    PHARMACOTHERAPY, 2012, 32 (06): : 546 - 558
  • [2] Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment
    Moumneh, T.
    Mallecian, Y.
    Calmes, A.
    Lacour, E.
    Roy, P. M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 360 - 361
  • [3] Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy
    Pearlman, Eugene
    Bibars, Wafi
    Willard, Jennifer
    Moore, Darlene
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A127 - A127
  • [4] Standardization of Anti-Xa Assay and its Comparison with Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin Therapy
    Thalappil, Vijisha
    Anand, Jeyanthi
    Keepanasseril, Anish
    Kar, Rakhee
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (03) : 432 - 436
  • [5] Monitoring Unfractionated Heparin: A Review of Activated Partial Thromboplastin Time Versus Antifactor Xa
    Parker, Christine R.
    Kataria, Vivek
    AACN ADVANCED CRITICAL CARE, 2019, 30 (04) : 305 - 312
  • [6] Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis
    Fuentes, Amaris
    Gordon-Burroughs, Sherilyn
    Hall, Jeffrey B.
    Putney, David R.
    Monsour, Howard P., Jr.
    THERAPEUTIC DRUG MONITORING, 2015, 37 (01) : 40 - 44
  • [7] CALCULATION-FREE HEPARIN NOMOGRAMS WITH ANTI-XA LEVELS VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME
    Kindelin, Nicole
    Anthes, Ananth
    Providence, Sarah
    Zhao, Xinhua
    Aspinall, Sherrie
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 416 - 416
  • [8] Comparing Anti-Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly W.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (08) : 801 - 805
  • [9] Comparing Activated Partial Thromboplastin Time and Heparin anti-Xa levels to monitor anticoagulant intensity of unfractionated heparin in Extracorporeal Membrane Oxygenation
    Dhillon, E.
    Laffan, M.
    Arachchillage, D. Jayakody
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 138 - 138
  • [10] Activated Partial Thromboplastin Time versus Anti-Factor Xa Levels for Monitoring Unfractionated Heparin Therapy in Children: An Institutional Experience
    Woods, Gary M.
    Stanek, Joseph
    Harrison, Sheilah
    Texter, Karen
    Kerlin, Bryce A.
    Dunn, Amy L.
    Kumar, Riten
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (07) : 576 - +
12345